Instil Bio, Inc. (TIL) — Financial statements
Income statement, balance sheet, and cash flow for Instil Bio, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.53 | 0.00 | 0.00↓100.0% | 6 | 0.00 | |
| Gross Profit | -0.53 | 0.00 | 0.00↑100.0% | -6 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 10↓15.5% | 12↓70.1% | 40↓71.9% | 141↑31.5% | 107 | |
| General & Administrative Expenses | 27↓38.4% | 44↓7.0% | 48↓23.6% | 62↑28.8% | 48 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 3 | |
| SG&A Expenses | 27↓38.4% | 44↓7.0% | 48↓23.6% | 62↑21.3% | 51 | |
| Other Expenses | 15↓13.4% | 17↓75.7% | 72↑2417.0% | -3↓3.6% | -3 | |
| Operating Expenses | 52↓28.8% | 74↓53.8% | 159↓20.5% | 200↑28.7% | 156 | |
| Total Costs & Expenses | 53↓28.1% | 74↓53.8% | 159↓22.8% | 206↑32.5% | 156 | |
| Operating Results | ||||||
| Operating Income | -53↑28.1% | -74↑53.8% | -159↑22.8% | -206↓32.5% | -156 | |
| Depreciation & Amortization | 0.53↓85.2% | 4↓24.1% | 5↓20.6% | 6↑117.6% | 3 | |
| EBITDA | -52↑16.2% | -63↑57.5% | -147↑32.3% | -217↓42.5% | -153 | |
| EBIT | -53↑20.0% | -66↑56.5% | -152↑32.0% | -223↓43.9% | -155 | |
| Interest & Other Income | ||||||
| Net Interest Income | -2↑1.7% | -2↓154.8% | 4↑106.4% | 2↑2115.0% | 0.08 | |
| Interest Income | 4↓44.8% | 7↓21.2% | 9↑142.6% | 4↑4468.8% | 0.08 | |
| Interest Expense | 6↓35.2% | 9↑72.6% | 5↑176.6% | 2 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -7↓1.5% | -7↓142.4% | 17↑5949.3% | -0.29 | |
| Other Income / Expenses | -18↓3008.6% | -0.59↓119.3% | 3↑116.2% | -19↓1496.7% | -1 | |
| Income Before Tax | -71↑3.7% | -74↑52.5% | -156↑30.7% | -225↓43.7% | -157 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00↑100.0% | -2↓5415.4% | 0.04 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -71↑3.7% | -74↑52.5% | -156↑30.1% | -223↓42.3% | -157 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -71↑3.7% | -74↑52.5% | -156↑30.1% | -223↓42.3% | -157 | |
| Bottom-Line Net Income | -71↑3.7% | -74↑52.5% | -156↑30.1% | -223↓42.3% | -157 | |
| EPS (Basic) | -10.70↑6.1% | -11.39↑52.5% | -24.00↑30.4% | -34.46↓16.4% | -29.60 | |
| EPS (Diluted) | -10.70↑6.1% | -11.39↑52.5% | -24.00↑30.4% | -34.46↓16.4% | -29.60 | |
| Weighted Average Shares | 7↑2.4% | 7↑0.1% | 7↑0.4% | 6↑22.2% | 5 | |
| Weighted Average Diluted Shares | 7↑2.4% | 7↑0.1% | 7↑0.4% | 6↑22.2% | 5 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.